Literature DB >> 18454466

Abnormalities in glucose tolerance are common in children with fanconi anemia and associated with impaired insulin secretion.

Deborah A Elder1, David A D'Alessio, Ori Eyal, Robin Mueller, Franklin O Smith, Alvina R Kansra, Susan R Rose.   

Abstract

BACKGROUND: To determine prevalence of abnormal glucose metabolism in Fanconi Anemia (FA). PROCEDURE: Thirty-nine children with FA underwent 2-hr oral glucose tolerance test (OGTT). Reference lean adolescents (REF) were older than FA patients (mean +/- SD: FA 8.6 +/- 3.9 years, REF 19.8 +/- 0.3 years, P < 0.001), but comparable in BMI Z-scores (FA 1.25 +/- 0.58, REF -0.02 +/- 0.24; P = 0.24). Patients had normal glucose tolerance (NGT) or abnormal glucose metabolism (AGM) by American Diabetes Association Criteria. Insulinogenic index estimated beta-cell function. Insulin resistance estimation used homeostatic model assessment (HOMA-IR). Insulin secretion estimation relative to insulin sensitivity used disposition index (DI).
RESULTS: Among FA patients, 46% had AGM. Compared to REF, there were significant differences in glycemic responses (area under curve: FA-NGT 344 +/- 42, FA-AGM 596 +/- 35, REF 208 +/- 25 mM, P < 0.0001) and insulinogenic index (FA-NGT 105 +/- 29, FA-AGM 44 +/- 8, and REF 173 +/- 41 pM/mM, P < 0.05). Insulin sensitivity did not differ among NGT, AGM, and REF (HOMA-IR: FA-NGT 1.9 +/- 0.4, FA-AGM 2.2 +/- 0.5, REF 1.3 +/- 0.2, P = NS). However, DI was significantly lower in both FA groups than REF [NGT 63.6 +/- 16.5 vs. AGM 26.4 +/- 3.5 (P < 0.048); REF 132.6 +/- 24.5 (NGT and AGM vs. REF, both P < 0.0002)].
CONCLUSION: Abnormalities in glucose metabolism are frequent in young FA patients without prior diagnosis of diabetes, and are associated with marked defects in insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18454466     DOI: 10.1002/pbc.21589

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  12 in total

Review 1.  Oxidative stress-associated protein tyrosine kinases and phosphatases in Fanconi anemia.

Authors:  Jie Li; Qishen Pang
Journal:  Antioxid Redox Signal       Date:  2014-03-11       Impact factor: 8.401

Review 2.  Molecular pathogenesis and clinical management of Fanconi anemia.

Authors:  Younghoon Kee; Alan D D'Andrea
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

3.  Endocrine evaluation of children with and without Shwachman-Bodian-Diamond syndrome gene mutations and Shwachman-Diamond syndrome.

Authors:  Kasiani C Myers; Susan R Rose; Meilan M Rutter; Parinda A Mehta; Jane C Khoury; Theresa Cole; Richard E Harris
Journal:  J Pediatr       Date:  2013-01-08       Impact factor: 4.406

4.  Tryptophan metabolism is dysregulated in individuals with Fanconi anemia.

Authors:  Allison L Bartlett; Lindsey Romick-Rosendale; Adam Nelson; Sheyar Abdullah; Nathan Luebbering; Jamen Bartlett; Marion Brusadelli; Joseph S Palumbo; Kelly Lake; Bridget Litts; Alexandra Duell; Annette Urbanski; Adam Lane; Kasiani C Myers; Susanne I Wells; Stella M Davies
Journal:  Blood Adv       Date:  2021-01-12

5.  Fanconi anemia links reactive oxygen species to insulin resistance and obesity.

Authors:  Jie Li; Jared Sipple; Suzette Maynard; Parinda A Mehta; Susan R Rose; Stella M Davies; Qishen Pang
Journal:  Antioxid Redox Signal       Date:  2012-06-25       Impact factor: 8.401

6.  Sex-specific hepatic lipid and bile acid metabolism alterations in Fancd2-deficient mice following dietary challenge.

Authors:  Elizabeth S Moore; Erin K Daugherity; David I Karambizi; Bethany P Cummings; Erica Behling-Kelly; Deanna M W Schaefer; Teresa L Southard; Joseph W McFadden; Robert S Weiss
Journal:  J Biol Chem       Date:  2019-08-21       Impact factor: 5.157

Review 7.  Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.

Authors:  Anna Petryk; Roopa Kanakatti Shankar; Neelam Giri; Anthony N Hollenberg; Meilan M Rutter; Brandon Nathan; Maya Lodish; Blanche P Alter; Constantine A Stratakis; Susan R Rose
Journal:  J Clin Endocrinol Metab       Date:  2015-01-09       Impact factor: 5.958

Review 8.  Fanconi anemia and its diagnosis.

Authors:  Arleen D Auerbach
Journal:  Mutat Res       Date:  2009-02-28       Impact factor: 2.433

9.  First phase insulin release and glucose tolerance in children with Fanconi anemia after hematopoietic cell transplantation.

Authors:  Lynda E Polgreen; William Thomas; Margaret L MacMillan; John E Wagner; Antoinette Moran; Anna Petryk
Journal:  Pediatr Blood Cancer       Date:  2009-08       Impact factor: 3.167

10.  Short telomeres compromise β-cell signaling and survival.

Authors:  Nini Guo; Erin M Parry; Luo-Sheng Li; Frant Kembou; Naudia Lauder; Mehboob A Hussain; Per-Olof Berggren; Mary Armanios
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.